RYEQO

This brand name is authorized in Austria, Croatia, Estonia, Finland, France, Ireland, Italy, Lithuania, Poland, Romania, Spain, UK.

Active ingredients

The drug RYEQO contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII P76B05O5V6 - RELUGOLIX
 

Relugolix is a nonpeptide GnRH receptor antagonist that competitively binds to GnRH receptors in the anterior pituitary gland preventing native GnRH from binding and signalling the secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). Consequently, the production of testosterone from the testes is reduced.

 
Read more about Relugolix
2
UNII CXY7B3Q98Z - ESTRADIOL HEMIHYDRATE
 

Estradiol, is chemically and biologically identical to endogenous human estradiol. It substitutes for the loss of oestrogen production in menopausal women, and alleviates menopausal symptoms. Oestrogens prevent bone loss following menopause or ovariectomy.

 
Read more about Estradiol
3
UNII 9S44LIC7OJ - NORETHINDRONE ACETATE
 

Norethisterone has progestational actions similar to those of progesterone, but is a more potent inhibitor of ovulation and has weak oestrogenic and androgenic properties. It is used to treat a number of disorders of the menstrual cycle.

 
Read more about Norethisterone

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 RYEQO Film-coated tablet MPI, EU: SmPC European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
H01CC54 H Systemic hormonal preparations, excl. Sex hormones and insulins → H01 Pituitary and hypothalamic hormones and analogues → H01C Hypothalamic hormones → H01CC Anti-gonadotropin-releasing hormones
Discover more medicines within H01CC54

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
EE Ravimiamet 1858103
ES Centro de información online de medicamentos de la AEMPS 1211565001
FI Lääkealan turvallisuus- ja kehittämiskeskus 456735, 565815
FR Base de données publique des médicaments 64049405
IT Agenzia del Farmaco 049616016, 049616028
LT Valstybinė vaistų kontrolės tarnyba 1093042
PL Rejestru Produktów Leczniczych 100455915
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W67879001

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.